Information for Sponsors
Emerging Viruses 2017 invites commercial sponsorship for demonstration of R&D and laboratory supplies related to virology, immunology and molecular biology. We offer a number of highly competitive packages (examples below). If your needs are not covered by the offered packages please contact us in the first instance and we shall do our best to develop a package to suit your requirements.
- Gold: Includes a speaker slot AND an exhibition stand, plus four free passes
- Silver: Includes a speaker slot OR an exhibition stand, plus three free passes
- Bronze: Includes exhibition stand, plus two free passes
- Drinks Reception
- Delegate Bags (max 2)
- Delegate Badges (max 2)
- Event Documentation (max 2)
- Exhibition stand
For Booking Form, terms and conditions, and further information about packages and other promotional opportunities email at:
Emerging Viruses 2017 Sponsors
Gold Sponsor and Exhibitor
The Native Antigen Company (NAC) specialises in the development and manufacture of native and recombinant viral and bacterial antigens, together with an expanding range of related antibodies and immunoassays. NAC’s antigens are used by pharmaceutical and IVD manufacturers in vaccine research and serology where correct folding and glycosylation are vital.
NAC has a particular interest in tropical diseases, and has a product pipeline including viral antigens for many emerging viruses that have been highlighted by the WHO as priorities for research and development in relation to vaccines, diagnostics and therapeutics.
As well as offering antigens from a rapidly expanding portfolio, NAC undertakes bespoke product development and custom manufacture using its proprietary mammalian cell protein expression system. A full service from protein production, antibody generation, to immunoassay development using ELISA and Lateral Flow techniques is available.
Gold Sponsor and Exhibitor
Absolute Antibody Ltd specialises in the sequencing, engineering, and recombinant expression of antibodies and Fc-fusion proteins. Recombinant antibody technology had been largely reserved for the pharmaceutical industry for decades, so we were founded in 2012 with the vision of bringing engineered antibodies to the wider research and diagnostics markets.
Recombinantly manufactured antibodies show minimal batch-to-batch variation and are ideal for use as standards and controls. In addition, we can convert any antibody into any format allowing us to offer each specificity in a range of species, isotypes and subtypes. This means our customers may ‘build’ an antibody to best suit their needs. Our ever-growing reagent catalogue now holds over 2500 products, including a large collection of anti-virus antibodies. Alternatively, we can or apply our recombinant technology to your own clone.
We are always happy to hear from researchers with ideas for new products and technology, so do stop by or get in touch for a chat – we’d love to meet you!